Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients

European Journal of Cardio-thoracic Surgery

Volumn 33, Issue 2, 2008, Pages 307-313

  Borasio, Piero ^a   Berruti, Alfredo ^a   Billé, Andrea ^a   Lausi, Paolo ^a   Levra, Matteo Giaj ^a   Giardino, Roberto ^a   Ardissone, Francesco ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Malignant pleural mesothelioma; Prognosis; Treatment

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED STUDY; DECORTICATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LABORATORY TEST; LOG RANK TEST; LUNG RESECTION; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; PLEURA MESOTHELIOMA; PLEURECTOMY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEX DIFFERENCE; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION; TUMOR BIOPSY; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; PLEURAL NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 38349051952     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2007.09.044     Document Type: Article

References (19)

1. Pelucchi C., Malvezzi M., La Vecchia C., Levi F., Decarli A., and Negri E. The mesothelioma epidemic in Western Europe: an update. Br J Cancer 90 (2004) 1022-1024
2. Edwards J.G., Abrams K.R., Leverment J.N., Spyt T.J., Waller D.A., and O'Byrne K.J. Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax 55 (2000) 731-735
3. Rusch V.W., and The International Mesothelioma Interest Group. A proposed new international TNM staging system for malignant pleural mesothelioma. Chest 108 (1995) 1122-1128
4. Lee T.T., Everett D.L., Shu H-KG, Jahan T.M., Roach III M., Speight J.L., Cameron R.B., Phillips T.L., Chan A., and Jablons D.M. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 124 (2002) 1183-1189
5. Sugarbaker D.J., Flores R.M., Jaklitsch M.T., Richards W.G., Strauss G.M., Corson J.M., DeCamp Jr. M.M., Swanson S.J., Bueno R., Lukanich J.M., Baldini E.H., and Mentzer S.J. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117 (1999) 54-65
6. Rusch V.W., Rosenzweig K., Venkatraman E., Leon L., Raben A., Harrison L., Bains M.S., Downey R.J., and Ginsberg R.J. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 122 (2001) 788-795
7. Boutin C., Rey F., Gouvernet J., Viallat J.R., Astoul Ph, and Ledoray V. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: prognosis and staging. Cancer 72 (1993) 394-404
8. Flores R.M. Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: the Memorial Sloan-Kettering experience. Lung Cancer 49S1 (2005) S71-S74
9. Edwards J.G., Stewart D.J., Martin-Ucar A., Muller S., Richards C., and Waller D.A. The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma. J Thorac Cardiovasc Surg 131 (2006) 981-987
10. Curran D., Sahmoud T., Therasse P., van Meerbeeck J., Postmus P.E., and Giaccone G. Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol 16 (1998) 145-152
11. Herndon J.E., Green M.R., Chahinian A.P., Corson J.M., Suzuki Y., and Vogelzang N.J. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the cancer and leukemia Group B. Chest 113 (1998) 723-731
12. Burgers J.A., and Damhuis R.A.M. Prognostic factors in malignant mesothelioma. Lung Cancer 45S1 (2004) S49-S54
13. Steele J.P.C. Prognostic factors in mesothelioma. Semin Oncol 29 (2002) 36-40
14. Spirtas R., Connelly R.R., and Tucker M.A. Survival patterns for malignant mesothelioma: the SEER experience. Int J Cancer 41 (1988) 525-530
15. Ruffie P., Feld R., Minkin S., Cormier Y., Boutan-Laroze A., Ginsberg R., Ayoub J., Shepherd F.A., Evans W.K., Figueredo A., Pater J.L., Pringle J.F., and Kreisman H. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 7 (1989) 1157-1168
16. Pass H.I. Pleural mesothelioma in 2002: going somewhere very slowly. J Thorac Cardiovasc Surg 124 (2002) 1074-1077
17. van Ruth S., Baas P., and Zoetmulder F.A.N. Surgical treatment of malignant pleural mesothelioma. A review. Chest 123 (2003) 551-561
18. Treasure T., and Sedrakyan A. Pleural mesothelioma: little evidence, still time to do trials. Lancet 364 (2004) 1183-1185
19. Maziak D.E., Gagliardi A., Haynes A.E., Mackay J.A., and Evans W.K. Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary. Lung Cancer 48 (2005) 157-169